Metformin may reduce side effects of systemic steroids: study
![Pill](https://www.ausdoc.com.au/wp-content/uploads/2022/08/white-pill-istock-1094642082-3.jpg)
Metformin reduces the metabolic complications of systemic glucocorticoid therapy while preserving its anti-inflammatory benefits, according to results from a proof-of-concept phase-2 trial.
UK researchers evaluated the potential of metformin to reduce the metabolic side effects of glucocorticoid therapy in their randomised, double-blind, placebo-controlled trial of 53 patients without diabetes but with an inflammatory disease treated with continuous prednisolone.